Modulation of immune functions in polymorphonuclear neutrophils induced by physostigmine, but not neostigmine, independent of cholinergic neurons

Immunobiology

Volumn 218, Issue 8, 2013, Pages 1049-1054

  Bitzinger, Diane I ^a   Zausig, York A ^a   Paech, Christoph ^a   Gruber, Michael ^a   Busse, Hendrik ^a   Sinner, Barbara ^a   Graf, Bernhard M ^a   Trabold, Benedikt ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cholinergic anti inflammatory pathway; Cholinesterase inhibitors; Immunomodulation; Mac 1; Non neuronal cholinergic system; Oxidative burst; Reactive oxygen species

Indexed keywords

BUNGAROTOXIN RECEPTOR; CD11B ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; L SELECTIN; NEOSTIGMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHYSOSTIGMINE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; CELL SURFACE; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY BURST;

ANIMALS; CELL ADHESION MOLECULES; CELLS, CULTURED; CHOLINERGIC NEURONS; CHOLINESTERASE INHIBITORS; HUMANS; L-SELECTIN; MACROPHAGE-1 ANTIGEN; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEOSTIGMINE; NEUTROPHILS; PHYSOSTIGMINE; RATS; RATS, WISTAR; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878584011     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.01.003     Document Type: Article

References (22)

1. Akinci S.B., Ulu N., Yondem O.Z., et al. Effect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathway. World J Surg. 2005, 29(11):1483-1489.
2. Aquilonius S.M., Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin. Pharmacokinet. 1986, 11(3):236-249.
3. Benna J.E., Dang P.M., Gaudry M., et al. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation, Regulation by protein kinase C-dependent and independent pathways. J. Biol. Chem. 1997, 272(27):17204-17208.
4. Bitzinger D.I., Schlachetzki F., Lindner R., Trabold B., Dittmar M.S. Flow-cytometric measurement of respiratory burst in rat polymorphonuclear granulocytes: comparison of four cell preparation procedures, and concentration-response evaluation of soluble stimulants. Cytometry 2008, 73A(7):643-650.
5. Brown K.A., Brain S.D., Pearson J.D., et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368(9530):157-169.
6. Chen Y.-X., Sato M., Kawachi K., Abe Y. Neutrophil-mediated liver injury during hepatic ischemia-reperfusion in rats. HBPD Int. 2006, 5(3):436-442.
7. Elsner J.L., Smith J.M., Ensor C.R. Intravenous neostigmine for postoperative acute colonic pseudo-obstruction. Ann. Pharmacother. 2012, 46(3):430-435.
8. Fröhlich D., Rothe G., Schwall B., et al. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br. J. Anaesth. 1997, 78(6):718-723.
9. Fujii T., Kawashima K. An independent non-neuronal cholinergic system in lymphocytes. Japan. J. Pharmacol. 2001, 85(1):11-15.
10. Grando S.A., Kawashima K., Kirkpatrick C.J., Wessler I. Recent progress in understanding the non-neuronal cholinergic system in humans. Life Sci. 2007, 80(24-25):2181-2185.
11. Hartvig P., Wiklund L., Lindström B. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients. Acta Anaesthesiol. Scand. 1986, 30(2):177-182.
12. Hartvig P., Lindström B., Pettersson E., Wiklund L. Reversal of postoperative somnolence using a two-rate infusion of physostigmine. Acta Anaesthesiol. Scand. 1989, 33(8):681-685.
13. Hofer S., Eisenbach C., Lukic I.K., et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit. Care Med. 2008, 36(2):404-408.
14. Kutsuna S., Tsuruta R., Fujita M., et al. Cholinergic agonist physostigmine suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in rats with forebrain ischemia/reperfusion. Brain Res. 2010, 1313:242-249.
15. Li W., Chung S.C.S. Flow cytometric evaluation of leukocyte function in rat whole blood. In Vitro Cell. Dev. Biol. Anim. 2003, 39(10):413-419.
16. Pavlov V.A., Tracey K.J. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem. Soc. Trans. 2006, 34(Pt 6):1037-1040.
17. Peter C., Schmidt K., Hofer S., et al. Effects of physostigmine on microcirculatory alterations during experimental endotoxemia. Shock 2010, 33(4):405-411.
18. Saeed R.W., Varma S., Peng-Nemeroff T., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 2005, 201(7):1113-1123.
19. Trabold B., Gruber M., Fröhlich D. Functional and phenotypic changes in polymorphonuclear neutrophils induced by catecholamines. Scand Cardiovasc J. 2007, 41(1):59-64.
20. Trabold B., Gruber M., Fröhlich D. Synthetic inotropes inhibit the expression of adhesion molecules and augment the expression of L-selectin in polymorphonuclear neutrophils. Resuscitation. 2007, 74(2):352-356.
21. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin. Invest. 2007, 117(2):289-296.
22. Wessler I., Kilbinger H., Bittinger F., Unger R., Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 2003, 72(18-19):2055-2061.